Advanced search
Publication Cover
Modern Rheumatology Volume 10, 2000 - Issue 4
Journal homepage
12
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Latent overproductive hyperuricemia increases in patients during the intermittent phase of gouty arthritis under long-term antihyperuricemic treatment

H. TsutaniFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, JapanCorrespondence[email protected]
,
C. KiribaFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, Japan
,
S. ImamuraFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, Japan
,
N. YoshioFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, Japan
,
T. NakamuraFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, Japan;Hayashi General Hospital, Fukui, Japan
&
T. UedaFirst Department of Internal Medicine, Fukui Medical University, School of Medicine, 23-3 Shimoaizuki, Matsuoka, Fukui 910-1193, Japan
Pages 207-210 | Received 04 Jun 1999, Accepted 20 Jun 2000, Published online: 02 Jan 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ippei Sakamaki, Kunihiro Inai & Hiroshi Tsutani. (2011) Safety of Intradermal Injection of Monosodium Urate Crystals as a Vaccine Carrier in Volunteers. Nucleosides, Nucleotides & Nucleic Acids 30:12, pages 1077-1084.
Read now

Articles from other publishers (1)

Daisuke Okui, Tomomitsu Sasaki, Masahiko Fushimi & Tetsuo Ohashi. (2019) The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor. Clinical and Experimental Nephrology 24:S1, pages 92-102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.